BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33648906)

  • 1. Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series.
    Frechet L; Puzenat E; Charollais R; Dresco F; Carlet C; Gallais-Serezal I; Nardin C; Aubin F
    Eur J Dermatol; 2021 Feb; 31(1):81-85. PubMed ID: 33648906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody.
    Minakawa S; Matsuzaki Y; Rokunohe D; Kumagai N; Kurose A; Kushibiki M; Kayaba H; Sawamura D
    Clin Exp Dermatol; 2021 Dec; 46(8):1586-1588. PubMed ID: 34096639
    [No Abstract]   [Full Text] [Related]  

  • 3. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases.
    Takahashi T; Yamasaki K; Terui H; Omori R; Tsuchiyama K; Fujimura T; Aiba S
    J Dermatol; 2019 Sep; 46(9):802-807. PubMed ID: 31271451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre study.
    Alzahrani M; Coste V; Konstantinou MP; Reguiai Z; Villani A; Hotz C; Viguier M; Pruvost-Balland C; Dupuy A; Wolkenstein P; Brun A; Aubin F; Sérézal IG
    Clin Exp Dermatol; 2023 Apr; 48(5):528-530. PubMed ID: 36702808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perifolliculitis Capitis Abscedens et Suffodiens Treated with Anti-tumor Necrosis Factor-alpha - Possible New Treatment Option.
    Sjerobabski Masnec I; Franceschi N
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):255-289. PubMed ID: 30390728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab.
    Martin-García RF; Rullán JM
    P R Health Sci J; 2015 Jun; 34(2):102-4. PubMed ID: 26061062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents.
    Mansouri Y; Martin-Clavijo A; Newsome P; Kaur MR
    Br J Dermatol; 2016 Apr; 174(4):916-8. PubMed ID: 26527324
    [No Abstract]   [Full Text] [Related]  

  • 8. Photodynamic therapy combined with dermatosurgical approach for Perifolliculitis Capitis Abscedens et Suffodiens.
    Cui X; Zhu J; Yao X; Zhu W; Xu P; Wu X
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101767. PubMed ID: 32305655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
    Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
    J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical interventions combined with photodynamic therapy in the treatment of Perifolliculitis Capitis Abscendens et Suffodiens: Report of 5 cases.
    Liu H; Ding A; Aloke G; Mvogo Ndzana LB; Wan M; Lin Y; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101660. PubMed ID: 32109620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab.
    Babalola F; Chima M; Jobarteh R; Gottlieb A
    J Drugs Dermatol; 2022 Mar; 21(3):313-314. PubMed ID: 35254754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe dissecting scalp cellulitis successfully treated with serial excisions in combination with anti-TNF therapy.
    Spiers J; Vinnicombe Z; Singh G; Pouncey A; McEvoy H
    Ann R Coll Surg Engl; 2021 Jun; 103(6):e199-e201. PubMed ID: 34058118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perifolliculitis capitis abscedens et suffodiens successfully treated with Saireito.
    Kurokawa I
    J Dermatol; 2019 Aug; 46(8):e299-e301. PubMed ID: 30809838
    [No Abstract]   [Full Text] [Related]  

  • 14. Approach to treatment of refractory dissecting cellulitis of the scalp: a systematic review.
    Thomas J; Aguh C
    J Dermatolog Treat; 2021 Mar; 32(2):144-149. PubMed ID: 31348693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short report on a case of Hoffman's perifolliculitis abscedens et suffodiens capitis. (Dissecting cellulitis of the scalp).
    KINGSLEY HJ
    Cent Afr J Med; 1962 May; 8():190. PubMed ID: 14456145
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissecting cellulitis of the scalp successfully treated with ALA-PDT: Case report.
    Zhan Y; Chen X; Zhou Y; Zou P; Xiao R
    Photodiagnosis Photodyn Ther; 2018 Dec; 24():182-184. PubMed ID: 30290230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinant factors of biological therapy for dissecting cellulitis of the scalp.
    Melgosa Ramos FJ; Berna-Rico E; Suarez-Valle A; Mateu Puchades A; Vañó-Galván S; García-Ruiz R; Saceda Corralo D
    J Dtsch Dermatol Ges; 2024 Jan; 22(1):115-117. PubMed ID: 38110849
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of recalcitrant dissecting cellulitis of the scalp with ALA-PDT: case report and literature review.
    Liu Y; Ma Y; Xiang LH
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):410-3. PubMed ID: 24284093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy combined with carbon dioxide laser pretreatment for treatment of perifolliculitis capitis abscedens et suffodiens: A case report.
    Huang J; Wang H
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104064. PubMed ID: 38527661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of dissecting cellulitis of the scalp with 10% ALA-PDT.
    Feng Y; Zhang Y; Guo H; Lin Z; Chen H; Wu Y; Gao XH; Chen HD
    Lasers Surg Med; 2019 Apr; 51(4):332-338. PubMed ID: 30136732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.